Loading stock analysis…
Evidence Synthesis
Last synthesized: 11 Jul 2026, 11:34
Evidence Synthesis
SOMANYCERA's gross margin accelerated to 32.37%, up from 7.95%.
The company's marginal operating leverage has also surged to , from 2.91%. Meanwhile, revenue growth has decelerated to , down from 76.8%. Earnings per share (EPS) has declined to INR, from 3.65 INR. The company's daily volume has slowed to shares, down from 191217 shares.
Source observations behind the synthesis narrative.
| Metric | Value | Previous Value | Trend |
|---|---|---|---|
| GROSS_MARGIN | 32.37 % | 7.95 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 7.95 % | 2.91 | ▲ |
| REVENUE_GROWTH_YOY | 6.4 % | 76.8 | ▼ |
| EPS_ACTUAL | 2.52 INR | 3.65 | ▼ |
| EPS_SURPRISE_PERCENT | -0.084 % | -0.117 | ▲ |
| PRICE_CHANGE_PERCENT | 0.216 % | — | - |
| DAILY_VOLUME | 52,138 shares | 1,91,217 | ▼ |
| CLOSE_PRICE | 509.5 INR | 508.4 | ▲ |
| NEWS_SENTIMENT_SCORE | 0.94 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 3 count | 12 | ▼ |
| TARGET_PRICE_PREMIUM | 12.7 % | — | - |